Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
Clinical trial NCT00972517 · COMPLETED
Trial details
- NCT number
- NCT00972517
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-29
- Primary completion
- 2010-11-22
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.